Long-Term Study of Safety and Efficacy of WelChol® as an Additional Therapy in Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

780

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Type 2 Diabetes
Interventions
DRUG

Colesevelam hydrochloride

Trial Locations (64)

Unknown

Birmingham

Tuscumbia

Jonesboro

Little Rock

Searcy

Carmichael

Concord

Irvine

La Jolla

Los Angeles

Los Gatos

San Diego

Spring Valley

West Hills

Washington D.C.

Cocoa Beach

Coral Gables

Largo

Miami

New Port Richey

Pembroke Pines

West Palm Beach

Atlanta

Chicago

Evansville

Indianapolis

Lexington

Louisville

New Orleans

Boston

Detroit

Troy

Edina

Kansas City

St Louis

Bozeman

Butte

Las Vegas

Rochester

Charlotte

Hickory

Statesville

Winston-Salem

Cincinnati

Cleveland

Marion

Perrysburg

Oklahoma City

Tulsa

Portland

Beaver

Charleston

Columbia

Bristol

Morristown

Corpus Christi

Dallas

Houston

Midland

San Antonio

Richmond

Lakewood

Mexico City

Lima

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY